SCHEMBL4906000

SCHEMBL4906000

CCc1ccc(S(=O)(=O)NCCc2coc(-c3ccc(C(C)(C)C)cc3)n2)cc1C(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.41
PPARA Q07869 3/20 0.41
SMN1; SMN2 Q16637 6/20 0.39
ALDH1A1 P00352 5/20 0.39
LMNA P02545 4/20 0.39
HTT P42858 2/20 0.39
POLB P06746 2/20 0.37
MAPT P10636 4/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PPARD Q03181 1/20 0.35
TP53 P04637 2/20 0.35
GSK3B P49841 1/20 0.34
NR1I2 O75469 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903596 0.92 PPARG (0.50) PPARGPPARASMN1; SMN2ALDH1A1LMNA
SCHEMBL4899812 0.92 PPARG (0.43) PPARGPPARASMN1; SMN2ALDH1A1LMNA
SCHEMBL4900708 0.91 PPARG (0.41) PPARGPPARASMN1; SMN2ALDH1A1LMNA
SCHEMBL4902454 0.88 LMNA (0.38) PPARGPPARASMN1; SMN2ALDH1A1LMNA
SCHEMBL4895720 0.86 PPARG (0.40) PPARGPPARASMN1; SMN2ALDH1A1LMNA
SCHEMBL4900873 0.84 PPARG (0.52) PPARGPPARASMN1; SMN2ALDH1A1LMNA
SCHEMBL4897574 0.84 LMNA (0.47) PPARGPPARASMN1; SMN2ALDH1A1LMNA
SCHEMBL4906842 0.83 LMNA (0.45) PPARGPPARASMN1; SMN2ALDH1A1LMNA
SCHEMBL4906173 0.83 MAPT (0.54) SMN1; SMN2ALDH1A1LMNAHTTPOLB
SCHEMBL4895920 0.82 LMNA (0.41) PPARGPPARASMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD PPARG 2/4885PPARA 1/4885SMN1; SMN2 3271/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD PPARG 2/4885PPARA 1/4885SMN1; SMN2 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.